Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020–2025)
Chemical Communications · 2026 · 62 (12) · 3662-3701
DOI: 10.1039/d5cc05629b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2026. Verfasst von Souleymane Sarr und 26 weiteren Autor:innen. Beteiligte Einrichtung: Université de Lorraine, CNRS, LCPM, F-54000 Nancy, France. Hauptthemen laut MEDLINE: Photochemotherapy, Pancreatic Neoplasms, Photosensitizing Agents, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Agence Nationale de la Recherche.
Abstract (Originalsprache)
This review will focus on the use of PDT with targeted photosensitisers or nanoparticles to treat pancreatic cancer in recent studies (2020–2025) from in vitro to in vivo experiments and clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Université de Lorraine, CNRS, LCPM, F-54000 Nancy, France.
- Université Paris Cité, CNRS, ITODYS, UMR 7086, 75013 Paris, France.
- Laboratoire LSAMM, UMR 7177, Institut de Chimie de Strasbourg, CNRS/UMR 7177, Université de Strasbourg, 4 rue Blaise Pascal, 67000 Strasbourg, France.
- Institut de Cancérologie Strasbourg Europe (ICANS), UNICANCER, Radiobiology Laboratory, Paul Strauss Comprehensive, Cancer Center, 67000 Strasbourg, France.
- Cube, UMR7357, Equipe Imagerie Multimodale Intégrative en Santé, Université de Strasbourg, France.
- Université de Lorraine, CNRS, CRAN, F-54505 Vandœuvre-lès-Nancy, France.
Förderung
- Agence Nationale de la Recherche
Zitieren
APA
Sarr, S., Godard, J., Valzer, E., Czuba, E., Acherar, S., Barberi-Heyob, M., Blanchard-Desce, M., Boleslawski, E., Brégier, F., Bulin, A. L., Burckel, H., Daouk, J., da Silva, A., Daniel, J., Delhem, N., Dewalle, A. S., Frochot, C., Gasser, G., Heitz, V., …, & Sol, V. (2026). Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020–2025). Chemical Communications, 62(12), 3662-3701. https://doi.org/10.1039/d5cc05629b
Vancouver
Sarr S, Godard J, Valzer E, Czuba E, Acherar S, Barberi-Heyob M, et al. Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020–2025). Chemical Communications. 2026;62(12):3662-3701. doi:10.1039/d5cc05629b
BibTeX
@article{Sarr2026,
author = {Sarr, Souleymane and Godard, Jérémy and Valzer, Emmanuel and Czuba, Elodie and Acherar, Samir and Barberi-Heyob, Muriel and Blanchard-Desce, Mireille and Boleslawski, Emmanuel and Brégier, Frédérique and Bulin, Anne-Laure and Burckel, Hélène and Daouk, Joël and da Silva, Anabela and Daniel, Jonathan and Delhem, Nadira and Dewalle, Anne-Sophie and Frochot, Céline and Gasser, Gilles and Heitz, Valérie and Jonckheere, Nicolas and Lemercier, Gilles and Mordon, Serge and Noël, Georges and Novell, Anthony and Ravanat, Jean-Luc and Roth, Gaël and Sol, Vincent},
title = {Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020–2025)},
journal = {Chemical Communications},
year = {2026},
volume = {62},
number = {12},
pages = {3662--3701},
doi = {10.1039/d5cc05629b}
}
EUVIMED